Delivery Order SPE2DE24DA011-SPE2D626F971L
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,066.83 to Arthrex Inc. for an Implant System, Sutureloc on April 24, 2025, with completion scheduled for April 29, 2025. This fixed-price delivery order with economic price adjustment was issued under a non-competitive award with no set-aside designation. Arthrex, headquartered in Naples, Florida, is a global leader in minimally invasive orthopedic medical technologies and surgical implants, serving...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,596.98 to Arthrex Inc. for an Implant System, SutureLoc on July 23, 2025. This fixed-price contract with economic price adjustment has a completion date of July 28, 2025, and will be performed in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $42,600.23 to Arthrex Inc. for an implant system featuring SutureLoc technology. The contract, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is issued without a set-aside designation, reflecting Arthrex's established competitive position as a primary supplier of orthopedic...
- The U.S. Department of Defense's Defense Logistics Agency Medical Supply Chain awarded Arthrex Inc. a delivery order valued at $19,688.56 for an Implant System, SutureLoc on June 2, 2025, with completion scheduled for June 5, 2025. This fixed-price delivery order with economic price adjustment was issued under the agency's broader federal contracting vehicle and will be performed in Naples, Florida, where Arthrex maintains its headquarters. The award carries no set-aside designation,...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical technologies based in Naples, Florida, has been awarded a delivery order valued at $2,200.44 for an Implant System SutureLoc under the Defense Logistics Agency's Medical Supply Chain program. The contract, issued without set-aside designation and effective through December 12, 2025, operates under a fixed-price structure with economic price adjustment provisions. This delivery order is executed as a parent contract,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $35,314.35 delivery order to Arthrex Inc. on November 18, 2025, for a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment features an ultimate completion date of November 21, 2025, and will be performed at Arthrex's headquarters in Naples, Florida. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in federal orthopedic procurement. Arthrex Inc., a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $41,272.55 for an Implant System, Sutureloc on August 7, 2025, with completion expected by August 12, 2025. This fixed-price delivery order with economic price adjustment is funded through the Defense Logistics Agency's Medical Supply Chain and was awarded without set-aside restrictions, reflecting Arthrex's strong competitive position in the federal...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $5,932.74 to Arthrex Inc. for a Proximal Tenodesis Implant System, effective September 29, 2025, with an ultimate completion date of October 2, 2025. This fixed-price contract with economic price adjustment clauses was awarded without a set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. The contractor, headquartered in Naples,...
- Arthrex Inc., a Naples, Florida-based manufacturer of minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $29,392.78 for an implant system called Sutureloc. The award, issued on November 24, 2025, with an ultimate completion date of November 28, 2025, is fixed-price with economic price adjustment provisions and carries no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, which procures orthopedic...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,970 to Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida. The delivery order, issued on October 14, 2025, with an ultimate completion date of October 17, 2025, calls for the supply of a Proximal Tenodesis Implant System. This fixed-price contract with economic price adjustment represents a non-set-aside competitive award to the established...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D626F971LDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,532.55 to Arthrex Inc. for an Implant System, Sutureloc on December 9, 2025, with completion scheduled for December 12, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation. Arthrex, headquartered in Naples, Florida, is a leading manufacturer of minimally invasive orthopedic medical technologies and serves as a primary supplier to Department of Defense and Department of Veterans Affairs healthcare systems. The delivery order is issued under Arthrex's comprehensive Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a five-year master contract valued at approximately $471 million effective through September 2029. The Implant System, Suturloc being procured is part of Arthrex's broad portfolio of orthopedic surgical implants and specialized instruments routinely supplied to VA medical centers and military healthcare facilities nationwide. As a single-award indefinite delivery contract, the master vehicle streamlines procurement for federal healthcare enterprises by enabling rapid access to Arthrex's comprehensive orthopedic solutions—including suture anchors, surgical implants, joint replacement systems, and biologics—without requiring competitive reevaluation on individual task orders. This delivery order reflects the continued reliance of the federal healthcare system on Arthrex's advanced orthopedic technologies to support surgical procedures for veteran and active-duty patient populations across multiple orthopedic specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 12/8/25 |